SCHEMBL1770045

SCHEMBL1770045

CC(=O)SCC(=O)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 3/20 0.49
▸ ALDH1A1 P00352 6/20 0.44
▸ TSHR P16473 2/20 0.44
▸ LMNA P02545 4/20 0.42
▸ HTT P42858 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ STAT6 P42226 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ ITGB1 P05556 1/20 0.39
▸ ITGA4 P13612 1/20 0.39
▸ PTGES O14684 1/20 0.39
▸ EPHX1 P07099 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11855394 0.80 HSD11B1 (0.51) HSD11B1ALDH1A1TSHRLMNAHTT
SCHEMBL8533984 0.74 ALDH1A1 (0.50) HSD11B1ALDH1A1TSHRLMNAHTT
SCHEMBL1072478 0.73 ALDH1A1 (0.50) HSD11B1ALDH1A1TSHRLMNA
SCHEMBL25568411 0.72 ALDH1A1 (0.52) HSD11B1ALDH1A1TSHRLMNAHTT
SCHEMBL17399690 0.72 HSD11B1 (0.44) HSD11B1ALDH1A1TSHRLMNAHTT
SCHEMBL1075076 0.71 ALDH1A1 (0.49) HSD11B1ALDH1A1TSHRLMNAHTT
SCHEMBL14341887 0.69 KDM4E (0.56) HSD11B1ALDH1A1TSHRLMNAHTT
SCHEMBL4474354 0.69 ALDH1A1 (0.47) HSD11B1ALDH1A1TSHRLMNAHTT
SCHEMBL2526513 0.69 ALDH1A1 (0.47) HSD11B1ALDH1A1TSHRLMNAHTT
SCHEMBL19757635 0.69 HSD11B1 (0.47) HSD11B1ALDH1A1TSHRLMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110112151-A1 COMPOUND CAPABLE OF INHIBITING 11-BETA HYDROXYSTERIOD DEHYDROGENASE STERIX LIMITED (GB) 2011-05-12 — — US disclosed
EP-2257528-A2 1 IBETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS Sterix Limited (GB) 2010-12-08 — — EP disclosed
WO-2009106817-A2 COMPOUND STERIX LIMITED (GB) 2009-09-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112151-A1 COMPOUND CAPABLE OF INHIBITING 11-BETA HYDROXYSTERIOD DEHYDROGENASE HSD11B1, HSD11B2, HSD3B1 HSD11B1 1/4885ALDH1A1 307/4885TSHR 1454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback